Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Édith Beaulieu"'
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 13, Iss 3, Pp 561-571 (2017)
We investigated the long-term immune profiles of dose-sparing, AS03-adjuvanted vaccines compared to a traditional high-dose, unadjuvated influenza vaccine formulation. BALB/c mice received 2 IM injections of influenza A/Uruguay/716/2007 (H3N2) split
Externí odkaz:
https://doaj.org/article/565526ab1d2b49618a14b6cf40a2301e
Autor:
Daniel Stadlbauer, Leon de Waal, Edith Beaulieu, Shirin Strohmeier, Edwin J. B. Veldhuis Kroeze, Philippe Boutet, Albert D. M. E. Osterhaus, Florian Krammer, Bruce L. Innis, Raffael Nachbagauer, Koert J. Stittelaar, Corey P. Mallett
Publikováno v:
npj Vaccines, Vol 6, Iss 1, Pp 1-10 (2021)
Abstract Human infections with avian H7N9 subtype influenza viruses are a major public health concern and vaccines against H7N9 are urgently needed for pandemic preparedness. In early 2013, novel H7N9 influenza viruses emerged in China that caused ab
Externí odkaz:
https://doaj.org/article/1f961e1904734a6b881c4f9a5ecc6653
Autor:
Marie-Eve Hamelin, Mariana Baz, Yacine Abed, Christian Couture, Philippe Joubert, Edith Beaulieu, Nathalie Bellerose, Martin Plante, Corey Mallett, Gregg Schumer, Gary P Kobinger, Guy Boivin
Publikováno v:
PLoS Pathogens, Vol 6, Iss 7, p e1001015 (2010)
The neuraminidase inhibitor oseltamivir is currently used for treatment of patients infected with the pandemic A/H1N1 (pH1N1) influenza virus, although drug-resistant mutants can emerge rapidly and possibly be transmitted. We describe the characteris
Externí odkaz:
https://doaj.org/article/898d5e52d03e4b6fbbc144f0479327d9